Radjenović Jelena, Petrović Mira, Barceló Damià
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034 Barcelona, Spain.
Water Res. 2009 Feb;43(3):831-41. doi: 10.1016/j.watres.2008.11.043. Epub 2008 Dec 7.
In this paper we report on the performances of full-scale conventional activated sludge (CAS) treatment and two pilot-scale membrane bioreactors (MBRs) in eliminating various pharmaceutically active compounds (PhACs) belonging to different therapeutic groups and with diverse physico-chemical properties. Both aqueous and solid phases were analysed for the presence of 31 pharmaceuticals included in the analytical method. The most ubiquitous contaminants in the sewage water were analgesics and anti-inflammatory drugs ibuprofen (14.6-31.3 microg/L) and acetaminophen (7.1-11.4 microg/L), antibiotic ofloxacin (0.89-31.7 microg/L), lipid regulators gemfibrozil (2.0-5.9 microg/L) and bezafibrate (1.9-29.8 microg/L), beta-blocker atenolol (0.84-2.8 microg/L), hypoglycaemic agent glibenclamide (0.12-15.9 microg/L) and a diuretic hydrochlorothiazide (2.3-4.8 microg/L). Also, several pharmaceuticals such as ibuprofen, ketoprofen, diclofenac, ofloxacin and azithromycin were detected in sewage sludge at concentrations up to 741.1, 336.3, 380.7, 454.7 and 299.6 ng/g dry weight. Two pilot-scale MBRs exhibited enhanced elimination of several pharmaceutical residues poorly removed by the CAS treatment (e.g., mefenamic acid, indomethacin, diclofenac, propyphenazone, pravastatin, gemfibrozil), whereas in some cases more stable operation of one of the MBR reactors at prolonged SRT proved to be detrimental for the elimination of some compounds (e.g., beta-blockers, ranitidine, famotidine, erythromycin). Moreover, the anti-epileptic drug carbamazepine and diuretic hydrochlorothiazide by-passed all three treatments investigated. Furthermore, sorption to sewage sludge in the MBRs as well as in the entire treatment line of a full-scale WWTP is discussed for the encountered analytes. Among the pharmaceuticals encountered in sewage sludge, sorption to sludge could be a relevant removal pathway only for several compounds (i.e., mefenamic acid, propranolol, and loratidine). Especially in the case of loratidine the experimentally determined sorption coefficients (Kds) were in the range 2214-3321 L/kg (mean). The results obtained for the solid phase indicated that MBR wastewater treatment yielding higher biodegradation rate could reduce the load of pollutants in the sludge. Also, the overall output load in the aqueous and solid phase of the investigated WWTP was calculated, indicating that none of the residual pharmaceuticals initially detected in the sewage sludge were degraded during the anaerobic digestion. Out of the 26 pharmaceutical residues passing through the WWTP, 20 were ultimately detected in the treated sludge that is further applied on farmland.
在本文中,我们报告了全尺寸传统活性污泥(CAS)处理工艺以及两个中试规模的膜生物反应器(MBR)在去除属于不同治疗类别且具有不同物理化学性质的多种药物活性化合物(PhACs)方面的性能。对水相和固相均进行了分析,以检测分析方法中包含的31种药物的存在情况。污水中最普遍存在的污染物是镇痛药和抗炎药布洛芬(14.6 - 31.3微克/升)和对乙酰氨基酚(7.1 - 11.4微克/升)、抗生素氧氟沙星(0.89 - 31.7微克/升)、调脂药吉非贝齐(2.0 - 5.9微克/升)和苯扎贝特(1.9 - 29.8微克/升)、β受体阻滞剂阿替洛尔(0.84 - 2.8微克/升)、降糖药格列本脲(0.12 - 15.9微克/升)以及利尿剂氢氯噻嗪(2.3 - 4.8微克/升)。此外,在污水污泥中还检测到几种药物,如布洛芬、酮洛芬、双氯芬酸、氧氟沙星和阿奇霉素,其浓度高达741.1、336.3、380.7、454.7和299.6纳克/克干重。两个中试规模的MBR对几种CAS处理工艺去除效果较差的药物残留(如甲芬那酸、吲哚美辛、双氯芬酸、异丙安替比林、普伐他汀、吉非贝齐)表现出更强的去除能力,而在某些情况下,其中一个MBR反应器在较长污泥停留时间(SRT)下更稳定的运行被证明对某些化合物(如β受体阻滞剂、雷尼替丁、法莫替丁、红霉素)的去除不利。此外,抗癫痫药物卡马西平和利尿剂氢氯噻嗪未被所研究的三种处理工艺去除。此外,还讨论了MBR以及全尺寸污水处理厂整个处理流程中污水污泥对所遇到分析物的吸附情况。在污水污泥中遇到的药物中,吸附到污泥上可能只是几种化合物(即甲芬那酸、普萘洛尔和氯雷他定)的一种相关去除途径。特别是对于氯雷他定,实验测定的吸附系数(Kds)在2214 - 3321升/千克范围内(平均值)。固相的结果表明,产生更高生物降解率的MBR污水处理可以降低污泥中的污染物负荷。此外,还计算了所研究污水处理厂水相和固相的总输出负荷,表明在厌氧消化过程中,最初在污水污泥中检测到的残留药物均未降解。在通过污水处理厂的26种药物残留中,有20种最终在进一步用于农田的处理后污泥中被检测到。